Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Inappropriate sinus tachycardia (IST) is a clinical syndrome characterized by excessive resting heart rate (HR) or a disproportional increase in HR during exercise. β-blocker or calcium channel-blocker therapy is often noneffective or not well tolerated. The HR reduction on ivabradine is similar to β-blockers but in some patients its efficacy to resolve all IST-related symptoms is limited. The aim of the study was to assess the efficacy and safety of combining ivabradine with metoprolol succinate in patients with refractory highly symptomatic IST. METHODS: Twenty patients (36 ± 10 years; 16 women) with IST were enrolled. All patients received metoprolol succinate 95 mg single dose during the first month of the study. After 4 weeks of treatment with metoprolol, ivabradine was administered as adjuvant therapy up to 7.5 mg twice daily. Holter monitoring and treadmill stress test were performed at baseline, after 4, and 8 weeks of the study, respectively. RESULTS: We observed significant and similar reduction in resting HR both for metoprolol and for combined therapy compared to the baseline. The mean HR during daily activity was significantly lower on ivabradine and metoprolol compared to monotherapy with β-blocker. The combined treatment yielded a significant increase in exercise capacity as assessed by treadmill stress test. After 4 weeks of combined therapy a significant reduction in IST-related symptoms, measured by means of the European Heart Rhythm Association score, was observed. CONCLUSION: Combining ivabradine with metoprolol is an effective and well-tolerated treatment option for IST in patients with refractory to monotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099 · cited 2×
“Phosphenes have also been reported in patients during drugs administration, especially a hallucinogen or ivabradine.(8,15,16) The important advantage of ivabradine over b-blockers is the lack of influence on systolic ventricular function, blood pressure, and lipid or glucose metabolism.”
BackgroundTardif, J.-C., Ford, I., Tendera, M., Bourassa, M. G., & Fox, K. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi586 · Cited by 582
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm358 · Cited by 380
Tardif, J.-C., Ponikowski, P., Kahan, T., & for the ASSOCIATE study Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn571 · Cited by 340
Mechanism of ”inappropriate” sinus tachycardia. Role of sympathovagal balance
Morillo, C. A., Klein, G. J., Thakur, R. K., Li, H., Zardini, M., & Yee, R. (1994) · Circulation · doi:10.1161/01.cir.90.2.873 · Cited by 193
Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia
Cappato, R., Castelvecchio, S., Ricci, C., Bianco, E., Vitali-Serdoz, L., Gnecchi-Ruscone, T., Pittalis, M., De Ambroggi, L., Baruscotti, M., Gaeta, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.031 · Cited by 159 · cited 3×
“The study showed that 1 month of monotherapy with ivabradine eliminates 70% of the variable symptoms associated with IST, but the complete elimination of symptoms can be expected in approximately half of the patients.(14) In a recent study from our group, metoprolol succinate was compared to ivabradine in a prospectiv…”
ResultRadiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping
Man, K. C., Knight, B., Tse, H.-F., Pelosi, F., Michaud, G. F., Flemming, M., Strickberger, S. A., & Morady, F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00546-x · Cited by 142
Prevalence, characteristics and natural course of inappropriate sinus tachycardia
STILL, A., RAATIKAINEN, P., YLITALO, A., KAUMA, H., IKAHEIMO, M., ANTEROKESANIEMI, Y., & HUIKURI, H. (2005) · Europace · doi:10.1016/j.eupc.2004.12.007 · Cited by 134
Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., & Wranicz, J. K. (2013) · Europace · doi:10.1093/europace/eus204 · Cited by 106
Self-citation
Research works printed but not linked: 1
- Kaplinsky E, 2010, Cardiol J, 17, 166
Cited by
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström-Lundqvist, C., Calkins, H., Corrado, D., Deftereos, S. G., Diller, G.-P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,230
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
“Furthermore, ivabradine can provide benefits when added to beta-blocker therapy.(64) Ivabradine is not yet available in all countries, although it might appear in the next 2–3 years.”
BackgroundPage, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
“an examination of the QRS morphology in the precordial leads (73), and the Vereckei algorithm, which is based”
BackgroundMethodInfluential2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
Inappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2019) · EP Europace · doi:10.1093/europace/euy128 · Cited by 80
Metadata
- Authors
- Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., Cygankiewicz, I., & Wranicz, J. K.
- Affiliations
- Medical University of Lodz (PL)
- Cardiology Practice Bonn, Bonn, Germany
- Corresponding author
- Ptaszynski, Pawel
- Venue
- Journal of Cardiovascular Pharmacology and Therapeutics
- Publisher
- SAGE Publications
- Published
- 2013-02-19
- Volume
- 18
- Issue
- 4
- Pages
- 338-344
- ISSN
- 1074-2484 (ISSN-L)
- 1940-4034
- OpenAlex
- W2122566237
- Cited by
- 57
- References
- 22
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 13 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 8 · 2013: 1
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cardiovascular Pharmacology and Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- inappropriate sinus tachycardia, ivabradine, metoprolol succinate, combination therapy, exercise capacity, symptom scores, adjuvant therapy
- MeSH terms
- Ivabradine, Adrenergic beta-Antagonists, Adult, Benzazepines, Drug Resistance, Drug Therapy, Combination, Exercise Test, Female, Humans, Male, Metoprolol, Middle Aged, Tachycardia, Sinus, Electrocardiography, Ambulatory, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia. https://app.cochat.ai/papers/10.1177/1074248413478172
- The paper
- Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., Cygankiewicz, I., & Wranicz, J. K. (2013). Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia. Journal of Cardiovascular Pharmacology and Therapeutics. https://doi.org/10.1177/1074248413478172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.